This issue of Radiation Medicine Rounds examines the latest advances in the use of radiation medicine in treatment of head and neck cancer. Head and neck cancer treatment has undergone major change over the course of the past few years and Head and Neck Cancer addresses current best practices in the light of the most recent evidence.
Head and Neck Cancer addresses a wide range of topics under the broad heading of head and neck oncology. In the initial section, the authors address therapeutic approaches with chapters on current and future treatments. Coverage is extensive and includes articles on IMRT, combined modality treatments, the use of targeted agents in conjunction with chemotherapy, the use of transoral robotic surgery followed by postoperative radiation therapy, and the use of particle therapy. The second section addresses issues of health services and covers palliative care, how to assess toxicity in patients, and issues of interpreting and integrating classic study data into treatment decisions. The third section examines the factors influencing clinical decisions ranging including biomarkers and image guidance.
- In-depth, up-to-date expert reviews and analysis of major new developments in all areas of Radiation Medicine
- Each issue edited by an authority in that subject area
- Each issue focused on a single major topic in Radiation Medicine, providing coverage of advances in radiation science, radiation medicine technology, radiation medicine practice, and assessment of recent quality and outcome studies
Series Description: Radiation Medicine Rounds is a review series providing a thorough analysis of new scientific, technologic, and clinical advances in all areas of radiation medicine. There will be an emphasis throughout on multidisciplinary approaches to the specialty, as well as an emphasis on quality and outcomes analysis. The goal is to provide authoritative, thorough assessment of a wide range of "hot topics" and emerging new data for the entire specialty of radiation medicine.
- I. Therapeutic Approaches:
- 1. Intensity-Modulated Radiation Therapy for Head and Neck Cancer: A Decade of Experience Demonstrates Improved Patient Outcomes, G. Brandon Gunn and Adam S. Garden,
- 2. Concurrent Chemoradiotherapy in Squamous Cell Cancers of the Head and Neck, Roy B. Tishler,
- 3. Targeted Therapy for Squamous Cell Carcinoma of the Head and Neck, Sharon A. Spencer,
- 4. Induction Chemotherapy in Head and Neck Cancer: A Standard of Care,Sewanti Limaye and Robert I. Haddad,
- 5. Postoperative Management Following Transoral Robotic Surgery for Oropharyngeal Carcinomas, Harry Quon and Benjamin Goldsmith,
- 6. Particle Therapy for Head and Neck Cancer, Danielle N. Margalit and Annie W. Chan,
- 7. Optimizing Treatment Strategies in Recurrent Head and Neck Cancers, Gregory J. Kubicek and Dwight E. Heron,
- II. Health Services in Head and Neck Cancer:
- 8. Beyond the Prospective Trial: Outcomes Research in Head and Neck Cancer, David J. Sher
- 9. Palliative Care and Symptom Management in the Head and Neck Cancer Patient, Tracy A. Balboni,
- 10. Toxicity Assessment and Reporting in Radiotherapy of Head and Neck Cancer, Kenneth Jensen and Cai Grau
- III. Factors Influencing Clinical Decisions:
- 11. Biomarkers and Molecular-Targeted Therapeutics in Squamous Cell Carcinoma of the Head and Neck, Raymond L. Chai and Jennifer R. Grandis,
- 12. Image-Guidance in the Radiotherapeutic Management of Head and Neck Cancer: Current Strategies and Ongoing Challenges, Allen M. Chen and James A. Purdy
About the Guest Editors
Dwight Heron, MD, is Chairman of Radiation Oncology at UPMC Shadyside, Vice chairman of Radiation Oncology at the University of Pittsburgh Cancer Institute, and Associate Professor of Radiation Oncology at the University of Pittsburgh School of Medicine
Roy Tishler, MD, Disease Center Leader, Head and Neck Radiation Oncology, Dana-Farber Cancer Center, Associate Professor of Radiation Oncology, Brigham and Women's Hospital
Charles Thomas Jr., MD, Professor and Chairman, Department of Radiation Medicine, and Professor of Hematology / Oncology, Knight Cancer Institute, Oregon Health and Science University.